These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 2249189
1. Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children. Belasco JB, Luery N, Scher C. Cancer; 1990 Dec 15; 66(12):2492-7. PubMed ID: 2249189 [Abstract] [Full Text] [Related]
2. Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study. Buchanan GR, Boyett JM, Pollock BH, Smith SD, Yanofsky RA, Ghim T, Wharam MD, Crist WM, Vietti TJ, Johnson W. Cancer; 1991 Jul 01; 68(1):48-55. PubMed ID: 2049752 [Abstract] [Full Text] [Related]
5. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, del Potro E, Debén G, Abella E, Bethencourt C, Ortín X, Brunet S, Ortega-Rivas F, Novo A, López R, Hernández-Rivas JM, Sanz MA, Feliu E, PETHEMA Group. Eur J Haematol; 2007 Feb 01; 78(2):102-10. PubMed ID: 17087744 [Abstract] [Full Text] [Related]
7. Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia. Leahey AM, Bunin NJ, Belasco JB, Meek R, Scher C, Lange BJ. Med Pediatr Oncol; 2000 May 01; 34(5):313-8. PubMed ID: 10797352 [Abstract] [Full Text] [Related]
8. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica. Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi AM, Messina C, Mori PG, Miniero R, Colella R, Basso G. J Clin Oncol; 1995 Oct 01; 13(10):2497-502. PubMed ID: 7595699 [Abstract] [Full Text] [Related]
12. Intensive retreatment of adults and children with acute lymphoblastic leukemia. Bassan R, Cornelli PE, Battista R, Terzi F, Buelli M, Rambaldi A, Viero P, D'Emilio A, Dini E, Barbui T. Hematol Oncol; 1992 Oct 01; 10(2):105-10. PubMed ID: 1592360 [Abstract] [Full Text] [Related]
13. Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study. Lauer SJ, Camitta BM, Leventhal BG, Mahoney DH, Shuster JJ, Adair S, Casper JT, Civin CI, Graham M, Kiefer G. Cancer; 1993 May 01; 71(9):2854-61. PubMed ID: 8467463 [Abstract] [Full Text] [Related]
18. Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy. Grenzebach J, Schrappe M, Ludwig WD, Parwaresch R, Zimmermann M, Gadner H, Riehm H, Reiter A, BFM-Group. Ann Hematol; 2001 Sep 01; 80 Suppl 3():B73-6. PubMed ID: 11757713 [Abstract] [Full Text] [Related]